During the past decade, Ematologia - TMO - Ospedale San Gerardo conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ematologia - TMO - Ospedale San Gerardo" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 7 trials, followed by "Northern Italy Leukemia Group" with 5 trials sponsored, "Fondazione Italiana Linfomi ONLUS" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "Fondazione per la Ricerca Ospedale Maggiore" with 3 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ematologia - TMO - Ospedale San Gerardo" #1 collaborator was "Associazione Italiana per la Ricerca sul Cancro" with 1 trials as a collaborator, "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 1 trials as a collaborator, "GRADE Onlus" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Hematology Project Foundation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Ematologia - TMO - Ospedale San Gerardo" are "Acute Lymphoblastic Leukemia" (2 trials), "Acute Myelogenous Leukemia" (2 trials), "Acute Promyelocytic Leukemia" (2 trials), "Non-Hodgkin's Lymphoma" (2 trials) and "Pregnancy" (2 trials). Many other conditions were trialed in "Ematologia - TMO - Ospedale San Gerardo" in a lesser frequency.

Most popular intervention types in "Ematologia - TMO - Ospedale San Gerardo" are "Drug" (12 trials), "Other" (6 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Observation" (2 trials), "BEAM" (1 trials), "Bevacizumab" (1 trials), "Bortezomib" (1 trials) and "CHOP" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ematologia - TMO - Ospedale San Gerardo" are 20 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ematologia - TMO - Ospedale San Gerardo". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Ematologia - TMO - Ospedale San Gerardo, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ematologia - TMO - Ospedale San Gerardo, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".